drug
Tislelizumab Plus Bevacizumab/Chemo Demonstrates Early Efficacy in Cervical Cancer
Posted in Medicine on 20th Jul, 2023
by Alex Muller
The addition of the PD-L1 inhibitor tislelizumab to standard bevacizumab and platinum-doublet chemotherapy in the first-line setting prolonged progression-free survival, produced encouraging responses, and was well tolerated in patients with cervical cancer.
New Alzheimer's drugs offer hope for bleak diagnosis but remain out of reach in UK
Posted in Medicine on 20th Jul, 2023
by Alex Muller
Estimates by Alzheimer's Research UK and Alzheimer's Society suggest 720,000 people in the UK would meet the treatment criteria used in the clinical trials of lecanemab and donanemab. But they need a diagnosis the NHS just can't deliver.
Most blood pressure meds found to reduce frequency of migraine headaches
Posted in Medicine on 27th Jun, 2023
by Alex Muller
A new study by researchers at The George Institute for Global Health in Sydney, Australia, has found that almost all classes of antihypertensives have some ability to reduce the frequency of headaches in migraine sufferers.
Lung cancer pill cuts risk of death by half, says ‘thrilling’ study
Posted in Medicine on 14th Jun, 2023
by Alex Muller
Taking the drug osimertinib once a day after surgery reduces chance of patients dying by 51%, trials show.
Olaparib approved for 800 prostate and breast cancer patients in England
Posted in Medicine on 20th May, 2023
by Alex Muller
When used after surgery and chemotherapy, the drug can also reduce the risk of BRCA-mutant, HER2-negative early breast cancer returning or getting bigger.